Do proton pump inhibitors affect the effectiveness of cyclin-dependent kinase 4/6 inhibitors in advanced HR positive, HER2 negative breast cancer? A meta-analysis-Reference-Cited by-同舟云学术

Do proton pump inhibitors affect the effectiveness of cyclin-dependent kinase 4/6 inhibitors in advanced HR positive, HER2 negative breast cancer? A meta-analysis

Published:2024-05-06 Issue: Volume:15 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Moraes Francisco Cezar Aquino de,Pereira Caroline R. M.,Sano Vitor Kendi Tsuchiya,Laia Estella Aparecida De,Stecca Carlos,Burbano Rommel Mario Rodríguez

Abstract

Graphical Abstract

Publisher

Frontiers Media SA

Reference62 articles.

1. Chapter 13: assessing risk of bias due to missing results in a synthesis2023

2. Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication;Bellet;Ther. Adv. Med. Oncol.,2019

3. A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer;Bilgin;Curr. Med. Res. Opin.,2017

4. Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?;Budha;Clin. Pharmacol. Ther.,2012

5. The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer;Çağlayan;Eur. J. Clin. Pharmacol.,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysis;Clinical and Translational Oncology;2024-08-18

2. Omitting Axillary Lymph Node Dissection Is Associated With an Increased Risk of Regional Recurrence in Early Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials;Clinical Breast Cancer;2024-08